MedicalDevice Licensing.com
Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

About Us
Pharmalicensing - Partnering solutions for the life sciences
 
Our Products
Overview
Partnering Search
Company Profiling
Deal Negotiation
PL Intelligence
Reports
Comparison
 
PL Intelligence
Overview
Industry news
Deals review
Press releases
Articles
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire
Jobs
 
Contact Pharmalicensing
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing
is a division of
UTEK Europe Ltd
UTEK Corporation
Companies

Medinnova

Medinnova
Medinnova identifies, protects and commercialises inventions and discoveries of the Oslo University Hospital and other health enterprises in the south-east of Norway.

The company in detail

Profile

Medinnova is the leading Technology Transfer Office (TTO) in life science and healthcare in Norway. Medinnova is dedicated to facilitate the process from early research idea to commercial product.

Our mission is to generate new products, services and business through out-lisensing of intellectual property resulting from research, spin-out company formation, consulting and material sales.

Medinnova provides access to worldclass medical research expertise and work close with the researchers to identify valuable project at a very early stage. Medinnova manage the further commercialisation process and covers all critical steps along the biomedicine and health care value chain.

Medinnova also manage different types of collaboration projects between international biotech-, medtech-, and pharmaceutical companies and leading basal, translational and clinical research groups at our hospitals.

Partnering strategy/interests

Medinnova seeks partners for licensing of intellectual property within novel therapy, diagnostics research tools, medical equipment and health related information and communication technologies (ICT).
For particular innovations we are as well interested in partners for research collaboration and commercial development. Medinnova is also seeking investors/partners for joint development and optimization of the potential in our startup companies.

Out-licensing

Heart failure mouse model feasible as testing of potential new drug candidates, test model for serious heart failure side effects and research in mechanisms of heart failure including compensatory mechanisms. More
The invention, reduced levels of specific amyloid β-protein degradation products are significantly reduced in macrophages from AD patients compared to controls, may form basis of a fast and predictive AD diagnostic assay More
A robust, computerized method for simultaneous detection and characterization of fusion gene combinations. Prior knowledge about likely translocations not required, can substitute PCR and FISH based testing in e.g. haematological cancer diagnosis. More
A non-invasive and robust hypermethylation assay for early diagnosis, prognosis and monitoring of colorectal cancer. The preliminary results are very encouraging indicating a sensitivity and specificity of more than 90% More

Clients in focus...

Get the Flash Player to see this rotator.

Partnering discussion free of charge
BioTrinity
Press releases: Pharmalicensing current industry press releases.

© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd UTEK Corporation All rights reserved. Terms and Conditions | Contact us